Linda Gillam, M.D., MPH, FACC, FAHA, FASE, chair, cardiovascular medicine, Atlantic Health System, suggests how ...
Shimadzu Medical Systems highlighted new features of its Trinias Interventional X-ray line at the America College of ...
A 12-year-old boy at Bambino Gesù Children’s Hospital in Rome, Italy, has become the world’s youngest patient to be bridged to a heart transplant with the SynCardia temporary Total Artificial Heart.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Electrophysiology (EP) technology has been advancing rapidly the past few years with new ablation tools to improve atrial fibrillation (AF) treatments, miniaturized diagnostic monitoring systems, and new implantable rhythm management devices that are making procedures much less invasive.
Senate Republicans led by Majority Leader Mitch McConnell (Ky.) unveiled the discussion draft of their own bill Thursday to replace the Affordable Care Act (ACA), popularly known as Obamacare, which overhauled and expanded health insurance coverage for millions of Americans.
June 22, 2017 — The U.S. Food and Drug Administration (FDA) has identified Vascular Solutions’ recent recall of its ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Pacemakers and other cardiac devices can help solve forensic cases, according to a study presented at the European Heart Rhythm Association (EHRA) EUROPACE - CARDIOSTIM 2017 conference, June 18-21 in Vienna, Austria. Devices revealed the time and cause of death in some cases where autopsy failed to do so.
BioTrace Medical Inc. announced that the company’s Tempo Temporary Pacing Lead was featured in an oral presentation and two live cases during the Transcatheter Valve Therapies (TVT) 2017 conference, June 14-17 in Chicago. Tamim Nazif, M.D., director of clinical services of the Structural Heart and Valve Center at NewYork-Presbyterian/Columbia University Medical Center, presented real-world experiences with the Tempo Lead from transcatheter aortic valve replacement (TAVR) cases.
Mount Sinai Heart and BioImage-2 LLC recently announced the start of the BioImage-2 study investigating the progression of vascular atherosclerotic plaque in patients who previously participated in the BioImage study.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
June 20, 2017 — Dutch medical device company Stroke2prevent BV recently announced it has received U.S. Food and Drug ...
June 20, 2017 — The U.S. Food and Drug Administration (FDA) said Maquet/Datascope is voluntarily performing a worldwide ...
Here are several updates in medical imaging contrast media agents. Two of the biggest news items were related to safety ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
The tenth special edition Image Wisely Radiation Safety Case is now available to help radiologists, imaging technologists and medical physicists assess their understanding of important radiation safety concepts, including dose monitoring and management.
DAIC Editor Dave Fornell takes a tour of some of the most innovative new cardiac ultrasound technologies at the American ...
June 16, 2017 — The U.S. Food and Drug Administration (FDA) has expanded the indication for GE Healthcare’s imaging ...